RaySearch Laboratories AB Series B | Cash Flow
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
24,967.00
78,701.00
93,490.00
198,085.00
155,901.00
90,764
Depreciation, Depletion & Amortization
53,926.00
58,194.00
56,504.00
67,339.00
70,790.00
18,230
Other Funds
29,990.00
27,126.00
23,242.00
11,319.00
26,333.00
32,323
Funds from Operations
58,949.00
109,769.00
126,752.00
254,105.00
200,358.00
141,317
Changes in Working Capital
27,667.00
59,496.00
15,326.00
133,257.00
52,877.00
37,155
Net Operating Cash Flow
31,282.00
50,273.00
111,426.00
120,848.00
147,481.00
178,472
Capital Expenditures
56,542.00
57,844.00
103,855.00
106,949.00
148,825.00
Sale of Fixed Assets & Businesses
-
-
-
-
693.00
Net Investing Cash Flow
56,542.00
57,844.00
103,855.00
106,949.00
148,132.00
Cash Dividends Paid - Total
-
-
-
8,570.00
-
Issuance/Reduction of Debt, Net
-
24,345.00
3,946.00
20,861.00
19,773.00
Net Financing Cash Flow
1,563.00
24,345.00
3,946.00
12,291.00
19,773.00
Net Change in Cash
23,644.00
17,854.00
3,620.00
28,015.00
16,436.00
Free Cash Flow
28,316.00
46,855.00
88,577.00
118,307.00
136,436.00
Change in Capital Stock
1,563.00
-
-
-
-
Exchange Rate Effect
53.00
1,080.00
5.00
1,825.00
2,686.00
About RaySearch Laboratories AB
View Profile
